Education
About Us
Working with TipRanks
Follow Us
HeartBeam (BEAT)
NASDAQ:BEAT
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.16Last Year’s EPS
-0.19Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 13, 2025
|% Change Since: -4.68%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with significant advancements in regulatory approvals, strategic collaborations, and commercial readiness efforts. While there are challenges related to financial constraints and dependencies on partnerships, the company's progress and strategic planning position it well for future commercialization and growth.Company Guidance
During the HeartBeam First Quarter 2025 Financial Results Conference Call, CEO Rob Eno and CFO Tim Cruickshank provided guidance on the company's progress and future plans. Key metrics discussed included the achievement of several milestones, such as the presentation of the VALID-ECG study results, which showed a high level of agreement (93.4%) between synthesized and standard 12-lead ECGs for arrhythmia assessment. The company anticipates FDA clearance for their 12-lead synthesis software by the end of the year, vital for their commercial launch. They also reported financial discipline, with $4.5 million used in operating activities in Q1, and completed an $11.5 million common stock public offering. HeartBeam plans to focus on securing FDA clearance and commercial readiness, targeting a $500 million U.S. market with a projected $50-$100 monthly revenue per patient. They are preparing for a commercial launch expected by the end of 2025, with infrastructure and strategic collaborations, such as with AccurKardia, enhancing their competitive positioning.FDA 510(k) Clearance and Progress
HeartBeam received foundational FDA 510(k) clearance for its system, including arrhythmia assessment. They are in positive discussions with the FDA for the 12-lead synthesis software and anticipate clearance by the end of the year.
VALID-ECG Study Success
The VALID-ECG study met its endpoint, supporting the FDA submission for the 12-lead synthesis software. The study showed a 93.4% agreement with standard 12-lead ECGs, demonstrating the effectiveness of HeartBeam's technology.
AccurKardia Collaboration
HeartBeam announced a strategic collaboration with AccurKardia to integrate FDA-cleared ECG algorithms, enhancing their commercial product and reducing time and expenses associated with developing their own solution.
Intellectual Property Expansion
HeartBeam has added two new issued U.S. patents, bringing the total to 20 worldwide, strengthening their proprietary technology position.
Commercial Readiness and Early Access Program
HeartBeam is progressing well towards commercial readiness, including testing with concierge accounts and patients, and has established a contract manufacturer for scaling.
Successful Fundraising
HeartBeam completed an $11.5 million common stock public offering, supporting their strategic funding approach and commercialization efforts.
---
BEAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BEAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2025 | $1.71 | $1.60 | -6.43% |
Mar 13, 2025 | $2.02 | $2.05 | +1.49% |
Nov 07, 2024 | $2.33 | $2.57 | +10.30% |
Aug 14, 2024 | $2.27 | $2.31 | +1.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does HeartBeam (BEAT) report earnings?
HeartBeam (BEAT) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is HeartBeam (BEAT) earnings time?
HeartBeam (BEAT) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BEAT EPS forecast?
BEAT EPS forecast for the fiscal quarter 2025 (Q2) is -0.16.
---